MALAT1 and Parkinson disease: The abovementioned study was conducted in both PD mice and microglial cell models and the effects of MALAT1 in microglia were equally established, suggesting that it mitigates NRF2 production by enriching the recruitment of EZH2 to the NRF2 promoter, which successively elevates ROS production.